On the other hand, the distribution of GFAP immunoreactive glial cells in both early ages AD mice treated with Nosustrophine showed a few scattered GFAP-reactive clusters, mainly in the hippocampal layers (Figure 5A,C). This evidence concerns the gene GFAP and Alzheimer disease.